A CASE OF A WEAK D-PRIMIPAROUS WOMAN CARRING A NOVEL VARIANT <i>RHD</i> GENE
-
- Shimada Satoko
- Division of Clinical Laboratory, Minami-soma General Hospital
-
- Yasuda Hiroyasu
- Division of Blood Transfusion and Transplantation Immunology, Fukushima Medical University Hospital
-
- Sato Sumako
- Division of Clinical Laboratory, Minami-soma General Hospital
-
- Kato Hiroshi
- Division of Clinical Laboratory, Minami-soma General Hospital
-
- Hashimoto Shinako
- Department of Obstetrics and Gynecology, Minami-soma General Hospital
-
- Komiya Hiromi
- Department of Obstetrics and Gynecology, Fukushima Medical University Hospital
-
- Noritake Yasuji
- Japanese Red Cross Fukushima Blood Center
-
- Ito Shoichi
- Japanese Red Cross Miyagi Blood Center
-
- Kikuchi Masaki
- Japanese Red Cross Miyagi Blood Center
-
- Sasaki Kana
- Japanese Red Cross Central Blood Institute
-
- Ogasawara Kenichi
- Japanese Red Cross Central Blood Institute
-
- Ohto Hitoshi
- Division of Blood Transfusion and Transplantation Immunology, Fukushima Medical University Hospital
Bibliographic Information
- Other Title
-
- 新たな変異型<i>RHD</i>遺伝子をもつweak D初妊婦の1例
Search this article
Description
Background: To prevent anti-D alloimmunization by D-positive RBCs derived from an infant or newborn, the administration of Rh human-immunoglobulin (RhIG) to D-negative women without anti-D antibody is recommended during pregnancy or at delivery. However, there is no guidance for pregnant woman with the weak D phenotype in Japan.<br> Case and Results: A primigravid woman was admitted to our hospital at 34 week's gestation. Her RhD typed as weak D because her RBCs were not agglutinated by the immediate spin method but were positive by the indirect antiglobulin test using a commercial anti-D reagent. RhIG was not administered to the woman during pregnancy or at delivery despite her first baby being D-positive. However, anti-D alloantibodies were not detected in her sera during pregnancy or at delivery. Her RHD gene was suspected to be D variant and analyzed. According to the sequencing results of the RHD gDNA and RHD cDNA derived from peripheral reticulocytes, the pregnant woman had a novel RHD gene with A>G mutation at the splicing acceptor site of intron 4. This intronic mutation may cause alternative splicing as a consequence of its generating a unique transcript with an 87 base insertion.<br> Conclusion: We experienced a case of a weak D primiparous woman in whom RhIG was not administered during the perinatal period or at delivery. Her first baby was D-positive. However, anti-D alloimmunization was not induced. She has a novel RHD(IVS4-2A>G) with A>G mutation at the splicing accepter site of intron 4. It was considered that abnormal splicing may have caused the weak D with a 29-amino acid insertion.<br>
Journal
-
- Japanese Journal of Transfusion and Cell Therapy
-
Japanese Journal of Transfusion and Cell Therapy 57 (3), 153-159, 2011
The Japan Society of Transfusion Medicine and Cell Therapy
- Tweet
Details 詳細情報について
-
- CRID
- 1390001205270900608
-
- NII Article ID
- 10029418304
-
- NII Book ID
- AA12159645
-
- ISSN
- 18830625
- 18813011
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed